After AI express, investors ask questions on the investor interaction platform: does your company produce Helicobacter pylori testing products? If so, is it for consumers’ own use?
Shanghai Kehua Bio-Engineering Co.Ltd(002022) (002022. SZ) said on the investor interaction platform on January 23 that the relevant products are still in the development process.